BONESUPPORT HOLDING AB

As of June 30, 2026, BONESUPPORT HOLDING AB carries a market capitalization of 14.00B, placing it among publicly traded companies globally. Its enterprise value stands at 13.57B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BONESUPPORT HOLDING AB's next confirmed earnings release is scheduled for February 18, 2027.

As of June 30, 2026, BONESUPPORT HOLDING AB has 65.49M shares outstanding.

As of June 30, 2026, BONESUPPORT HOLDING AB trades at a trailing price-to-earnings ratio of 60.56. The price-to-sales ratio is 11.03, and the price-to-book ratio stands at 14.74.

As of June 30, 2026, BONESUPPORT HOLDING AB trades at an EV/EBITDA multiple of 44.26 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 10.63 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 45.50 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. BONESUPPORT HOLDING AB trades at an EV/FCF ratio of 56.74, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 13.57B versus a market cap of 14.00B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, BONESUPPORT HOLDING AB maintains a current ratio of 5.44, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, BONESUPPORT HOLDING AB posted a return on equity (ROE) of 27.50, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 28.43 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 23.07, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.14, useful for judging operating efficiency across full business cycles. The company generates approximately 9.19M in revenue per employee across its workforce of 139.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.70 indicates how many times BONESUPPORT HOLDING AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, BONESUPPORT HOLDING AB recorded 52.30M in income tax expense. That works out to an effective tax rate of 18.37, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 284.78M, leaving 232.48M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, BONESUPPORT HOLDING AB's stock has gained approximately 35.24% over the past 52 weeks. The 50-day moving average sits at 232.15, while the 200-day moving average is 216.47.

Over the twelve months ended June 30, 2026, BONESUPPORT HOLDING AB generated 1.28B in revenue and converted that into 232.48M in net income, yielding earnings per share of 3.48. EBITDA reached 306.69M, while operating income came in at 298.35M.

As of June 30, 2026, BONESUPPORT HOLDING AB holds 434.31M in cash and equivalents against 10.13M in total debt, resulting in a net debt position of -434.31M. Total book value stands at 949.66M, with working capital of 741.09M providing operational flexibility.

BONESUPPORT HOLDING AB produced 245.60M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.35M in capital expenditures, free cash flow totaled 239.25M - equivalent to 3.63 per share.

Over the twelve months ended June 30, 2026, BONESUPPORT HOLDING AB posted a gross margin of 91.92, reflecting its pricing power and cost economics. The operating margin of 23.37 and net profit margin of 18.21 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.68, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.01, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to BONESUPPORT HOLDING AB shareholders.

As of June 30, 2026, BONESUPPORT HOLDING AB has an Altman Z-Score of 51.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.